S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
PwC Australia sidelines 9 directors as leak of tax information investigated
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
3 Free Stock Picks per Day (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Sleepless in Kyiv: Nighttime Russian air campaign terrorizes citizens in Ukrainian capital
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
PwC Australia sidelines 9 directors as leak of tax information investigated
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
3 Free Stock Picks per Day (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Sleepless in Kyiv: Nighttime Russian air campaign terrorizes citizens in Ukrainian capital
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
PwC Australia sidelines 9 directors as leak of tax information investigated
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
3 Free Stock Picks per Day (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Sleepless in Kyiv: Nighttime Russian air campaign terrorizes citizens in Ukrainian capital
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
PwC Australia sidelines 9 directors as leak of tax information investigated
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
3 Free Stock Picks per Day (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Sleepless in Kyiv: Nighttime Russian air campaign terrorizes citizens in Ukrainian capital
NASDAQ:SNSE

Sensei Biotherapeutics (SNSE) Earnings Date, Estimates & Call Transcripts

$1.42
+0.05 (+3.26%)
(As of 05/26/2023 03:59 PM ET)
Compare
Today's Range
$1.38
▼
$1.45
50-Day Range
$1.31
▼
$1.81
52-Week Range
$1.28
▼
$2.39
Volume
7,400 shs
Average Volume
62,562 shs
Market Capitalization
$44.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Aug. 8Estimated
Actual EPS
(Mar. 28)
-$0.40 Beat By $0.01
Consensus EPS
(Mar. 28)
-$0.41
Last Year's Q1 EPS
(3/10/2022)
-$0.29
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

SNSE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SNSE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Sensei Biotherapeutics Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20232($0.51)($0.35)($0.43)
Q2 20232($0.59)($0.35)($0.47)
Q3 20232($0.63)($0.35)($0.49)
Q4 20232($0.66)($0.35)($0.51)
FY 20238($2.39)($1.40)($1.90)

SNSE Earnings Date and Information

Sensei Biotherapeutics last issued its earnings results on March 28th, 2023. The reported ($0.40) EPS for the quarter, topping analysts' consensus estimates of ($0.41) by $0.01. Sensei Biotherapeutics has generated ($1.51) earnings per share over the last year (($1.51) diluted earnings per share). Earnings for Sensei Biotherapeutics are expected to decrease in the coming year, from ($1.31) to ($1.56) per share. Sensei Biotherapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 8th, 2023 based off prior year's report dates.

Sensei Biotherapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/8/2023
(Estimated)		        
3/28/2023Q4 2022($0.41)($0.40)+$0.01($0.40)
11/8/2022Q3 2022($0.37)($0.44)($0.07)($0.44)
8/9/2022Q2 2022($0.40)($0.34)+$0.06($0.34)
5/10/2022Q1 2022($0.35)($0.40)($0.05)($0.40)    
3/10/2022Q4 2021($0.34)($0.29)+$0.05($0.29)
11/8/20219/30/2021($0.25)($0.32)($0.07)($0.32)
8/3/20216/30/2021($0.29)($0.32)($0.03)($0.32)
5/11/2021Q1($0.3040)($0.42)($0.1160)($0.42)












Sensei Biotherapeutics Earnings - Frequently Asked Questions

When is Sensei Biotherapeutics's earnings date?

Sensei Biotherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 8th, 2023 based off last year's report dates. Learn more on SNSE's earnings history.

Did Sensei Biotherapeutics beat their earnings estimates last quarter?

In the previous quarter, Sensei Biotherapeutics (NASDAQ:SNSE) reported ($0.40) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.41) by $0.01. Learn more on analysts' earnings estimate vs. SNSE's actual earnings.

How much profit does Sensei Biotherapeutics generate each year?

Sensei Biotherapeutics (NASDAQ:SNSE) has a recorded net income of -$48.59 million. SNSE has generated -$1.51 earnings per share over the last four quarters.

What is Sensei Biotherapeutics's EPS forecast for next year?

Sensei Biotherapeutics's earnings are expected to decrease from ($1.31) per share to ($1.56) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:SNSE) was last updated on 5/29/2023 by MarketBeat.com Staff

My Account -